Literature DB >> 2294889

Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis.

R W Baumhefner1, W W Tourtellotte, K Syndulko, V Waluch, G W Ellison, L W Meyers, S N Cohen, M Osborne, P Shapshak.   

Abstract

Magnetic resonance imaging (MRI) of the cerebrum, cerebellum, brain stem, and upper cervical cord was performed in 62 individuals with clinically definite chronic, progressive multiple sclerosis (MS). The total area of MRI-demonstrated lesions was measured from film enlargements for each region using an interactive image analysis system. While the MRI was abnormal in 60 (97%) of 62 patients, the visual-evoked potentials in 51 (85%) of 60 patients, the brain stem auditory-evoked potentials (BAEPs) in 24 (46%) of 52 patients, and the somatosensory-evoked potentials (SSEPs) in 45 (89%) of 54 patients, an abnormal intra-blood-brain barrier (BBB) IgG synthesis rate, IgG oligoclonal bands, or both were found in all 62 patients. The total area of MRI abnormality in the cerebrum was significantly correlated only with the intra-BBB IgG synthesis rate, abnormal visual-evoked potentials, impaired performance on the Symbol Digit Modalities Test (SDMT), and one test of standing duration in the quantitative examination of neurologic function (QENF). The brain stem lesion area correlated with the Kurtzke expanded disability status scale and brain stem functional systems score, the ambulation index, abnormal BAEPs, and impaired performance on the SDMT as well as multiple tests of upper and lower extremity function in the QENF. The cerebellar lesion area correlated with impaired performance on the SDMT and primarily upper extremity testing in the QENF.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2294889     DOI: 10.1001/archneur.1990.00530010027014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

1.  Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

Authors:  M Rovaris; D Barnes; N Woodrofe; G H du Boulay; J W Thorpe; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

2.  A study of oligoclonal band negative multiple sclerosis.

Authors:  A Z Zeman; D Kidd; B N McLean; M A Kelly; D A Francis; D H Miller; B E Kendall; P Rudge; E J Thompson; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

3.  Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.

Authors:  C Liu; S Edwards; Q Gong; N Roberts; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

4.  The role of the cerebellum in multiple sclerosis.

Authors:  Katrin Weier; Brenda Banwell; Antonio Cerasa; D Louis Collins; Anne-Marie Dogonowski; Hans Lassmann; Aldo Quattrone; Mohammad A Sahraian; Hartwig R Siebner; Till Sprenger
Journal:  Cerebellum       Date:  2015-06       Impact factor: 3.847

5.  Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids.

Authors:  R W Baumhefner; W W Tourtellotte; K Syndulko; A Staugaitis; P Shapshak
Journal:  Ital J Neurol Sci       Date:  1989-02

Review 6.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

7.  Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; S Mammi; V Martinelli; T Locatelli; G Scotti; S Amadio; N Canal; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

8.  Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.

Authors:  S Beer; K M Rösler; C W Hess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

Review 9.  Hypersensitivity Responses in the Central Nervous System.

Authors:  Reza Khorooshi; Nasrin Asgari; Marlene Thorsen Mørch; Carsten Tue Berg; Trevor Owens
Journal:  Front Immunol       Date:  2015-10-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.